TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase. - Test2 - elhamkhani - TriplyDB

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.

http://www.wikidata.org/entity/Q53090999

about

AXL kinase as a novel target for cancer therapy Axl as a mediator of cellular growth and survival Long-acting progestin-only contraceptives impair endometrial vasculature by inhibiting uterine vascular smooth muscle cell survival.Anoikis evasion in inflammatory breast cancer cells is mediated by Bim-EL sequestration Breast cancer subtype dictates DNA methylation and ALDH1A3-mediated expression of tumor suppressor RARRES1 AXL modulates extracellular matrix protein expression and is essential for invasion and metastasis in endometrial cancer.Giving AXL the axe: targeting AXL in human malignancy.The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta.Expression and clinicopathological correlations of retinoid acid receptor responder protein 1 in renal cell carcinomas.Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma.Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells.

P2860

Q26863442-7439A1E4-A226-4CC6-BBB8-EF6E770214DB Q34619118-98591257-C83D-428B-85D2-A99649707F67 Q35549107-9BC5ACCE-6D04-4084-897C-4CEB20532756 Q35829855-142AE4E5-7023-40CA-8070-EBAF5EBE65BE Q37536796-918474F9-5A04-4750-9E26-E22AD8966830 Q37684598-EA454733-875D-4984-9B32-2F9BDD9223EA Q38772267-1C67EE97-40AC-48D5-BDD4-EB6EE9167F69 Q38890318-922A7535-A7EE-46D4-A9FA-7419E50B7DB6 Q42243028-046490DC-D885-4138-A7A2-54E7736D261C Q49805080-C1F8D6B9-512C-4B2E-912D-8DCD14CD8B5B Q51684494-94649D94-0814-4CE9-9882-F5AF3C50AB07 Q53352729-20800817-D956-44D8-B871-D352D41876C1 Q55502534-22A5359C-626B-4DE0-AE66-1371D5216D6D

P2860

TIG1 promotes the development and progression of inflammatory breast cancer through activation of Axl kinase.

http://www.wikidata.org/entity/Q53090999

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

TIG1 promotes the development ...... ough activation of Axl kinase.

@en

TIG1 promotes the development ...... ough activation of Axl kinase.

@nl

type

label

TIG1 promotes the development ...... ough activation of Axl kinase.

@en

TIG1 promotes the development ...... ough activation of Axl kinase.

@nl

prefLabel

TIG1 promotes the development ...... ough activation of Axl kinase.

@en

TIG1 promotes the development ...... ough activation of Axl kinase.

@nl

P1433

Q53090999-AA0D8FE5-220A-4460-A35A-8273838248E8

P1476

Q53090999-0F04E006-AC1E-4EED-A69F-594DCC4537C1

P2093

Q53090999-0B2D79F1-F4A7-4287-A938-48487AEEE091

Q53090999-16BD1B85-69E4-4AD1-8D31-617D9C376EF7

Q53090999-43319263-094E-4E68-B3D9-E3F77FCAD530

Q53090999-5BBCB7C1-0503-4792-B087-B8F973D16177

Q53090999-9429F7C8-F9C5-4E55-9E47-1353086E34D9

Q53090999-C7987F93-4546-46FB-A768-BBCD787E917E

Q53090999-CB1848E7-7827-4498-951C-F06BACD53458

Q53090999-D3B0B7D9-11CC-4CF3-88C6-06733C623CC7

Q53090999-D65ECA38-E5F7-4C71-AC87-7B0E2161752B

Q53090999-E33E5119-70C4-40E5-8502-523B5474C6FC

P2860

Q53090999-18B2344C-4E90-42A7-9ECE-28F2A1320FAF

Q53090999-3C4AD3E6-4B96-464F-9CDD-74BA882E88DF

Q53090999-4496772B-63E9-4623-8511-DD0A5FF8579E

Q53090999-4926062E-E470-44DE-9BBC-EE1B3BCB49AB

Q53090999-4A5E567E-9B6E-4258-A9B8-D703FD8F13F1

Q53090999-534125E5-9188-4ABF-BF7E-458F8B5537FF

Q53090999-542A12C2-D5F4-4AE1-8069-EE1D677AE958

Q53090999-74B67BD4-A247-47AF-AC10-E01E9C95BB8C

Q53090999-76FB84BD-8B47-4945-991A-D81DAE138707

Q53090999-9114A513-617A-4791-BB4E-AB1C33BF58BA

P304

Q53090999-34C58721-E8A7-4CFF-9FC6-B327C8DCCD73

P31

Q53090999-DC4520D4-B327-4445-9B2E-B08D945DB574

P356

Q53090999-E0D50417-35E6-42FD-892F-81529030F7CB

P407

Q53090999-3999EEFE-5B01-4E38-A04D-A92856952AAB

P433

Q53090999-2A596239-9F33-481F-AB76-7C4C6D057CD4

P478

Q53090999-FAFC4BC9-8DD6-40A4-ADC8-52728249B399

P50

Q53090999-29C8F4FD-F606-433E-8039-33475615DC95

Q53090999-4D59CE4E-E09D-4174-B248-72141DC6F2EA

P577

Q53090999-10AD702E-4F26-48E4-8D40-ABE65D47890E

P698

Q53090999-10E64EAA-CEB8-468A-8F96-D455ED3CEAF5

P921

Q53090999-2463BADA-1145-4178-A287-758CEF51A167

P932

Q53090999-84064BDB-C69D-432B-8754-CCA9B354F5F3

P356

0008-5472.CAN-13-0967

P1433

Cancer Research

P1476

TIG1 promotes the development ...... ough activation of Axl kinase.

@en

P2093

Gabriel N Hortobagyi

http://www.w3.org/2001/XMLSchema#string

Hitomi Saso

http://www.w3.org/2001/XMLSchema#string

James M Reuben

http://www.w3.org/2001/XMLSchema#string

Lajos Pusztai

http://www.w3.org/2001/XMLSchema#string

Mien-Chie Hung

http://www.w3.org/2001/XMLSchema#string

Naoto T Ueno

http://www.w3.org/2001/XMLSchema#string

Steven L Warner

http://www.w3.org/2001/XMLSchema#string

Takayuki Iwamoto

http://www.w3.org/2001/XMLSchema#string

Weiya Xia

http://www.w3.org/2001/XMLSchema#string

Xiaoping Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Tazarotene-induced gene 1 (TIG1), a novel retinoic acid receptor-responsive gene in skin

Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer

Tumor metastasis: mechanistic insights and clinical challenges

Recent developments in receptor-selective retinoids.

Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

Tazarotene-induced gene 1 (TIG1) expression in prostate carcinomas and its relationship to tumorigenicity.

Molecular characterisation of cell line models for triple-negative breast cancers.

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

P304

6516-6525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-13-0967

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P50

David J. Bearss

Wendy A Woodward

P577

2013-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24014597

http://www.w3.org/2001/XMLSchema#string

P921

P932

6135947

http://www.w3.org/2001/XMLSchema#string